**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 606-20-2 |2,6-Dinitrotoluene | 99 | 210-106-0 |
|----------------|--------------------------------------|----------|-----------|
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: T
Risk Phrases: 23/24/25 45 48/22 62 52/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic by inhalation, in contact with skin and if swallowed. May
cause cancer. Harmful : danger of serious damage to health by
prolonged exposure if swallowed. Possible risk of impaired
fertility. Harmful to aquatic organisms, may cause long-term adverse
effects in the aquatic environment.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
Harmful if swallowed. Causes gastrointestinal irritation with
nausea, vomiting and diarrhea. May cause methemoglobinemia, cyanosis
(bluish discoloration of skin due to deficient oxygenation of the
blood), convulsions, and death. Methemoglobinemia is characterized by
dizziness, drowsiness, headache, shortness of breath, cyanosis
(bluish discoloration of skin due to deficient oxygenation of the
blood), rapid heart rate and chocolate-brown colored blood. May
cause allergic reaction.
Inhalation:
May cause respiratory tract irritation. Methemoglobinemia is
characterized by dizziness, drowsiness, headache, shortness of
breath, cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), rapid heart rate and chocolate-brown
blood.
Chronic:
Prolonged exposure may cause anemia and methemoglobinemia,
characterized by dizziness, drowsiness, headache, breath shortness,
cyanosis (bluish skin due to deficient oxygenation of the blood),
rapid heart rate and chocolate-brown colored blood. May cause cancer
according to animal studies.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use water fog, dry chemical, carbon dioxide, or regular foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Keep away
from reducing agents. Separate from oxidizing materials.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other
engineering controls to control airborne levels below recommended
exposure limits.
Exposure Limits
CAS# 606-20-2:
United States OSHA: 1.5 mg/m3 TWA (listed under Dinitrotoluene
(mixed isomers)).
Belgium - TWA: (listed as dinitrotoluene (mixed isomers)): 0.15 m
VLE
Germany: 0.007 ppm TWA; 0.05 mg/m3 TWA
Germany: Skin absorber
Malaysia: (listed as dinitrotoluene (mixed isomers)): 0.2 mg/m3 T
Spain: 0.15 mg/m3 VLA-ED
CAS# 25321-14-6:
United States OSHA: 1.5 mg/m3 TWA
Belgium - TWA: 0.15 mg/m3 VLE
Malaysia: 0.2 mg/m3 TWA
Spain: 0.15 mg/m3 VLA-ED
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Needles
Color: slightly yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: 1 mm Hg @ 20 deg C
Viscosity: Not available.
Boiling Point: 250 deg C
Freezing/Melting Point: 64-70 deg C
Autoignition Temperature: Not available.
Flash Point: 207 deg C ( 404.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: practically insoluble
Specific Gravity/Density:
Molecular Formula: C7H6N2O4
Molecular Weight: 182.14
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. There are instances
of explosion during manufacture or storage. May explode when heated.
Conditions to Avoid:
Excess heat.
Incompatibilities with Other Materials:
Oxidizing agents, reducing agents, strong bases, mixture with nitric
acid is highly explosive, ignites on contact with sodium oxide.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 606-20-2: XT1925000
CAS# 25321-14-6: XT1300000
LD50/LC50:
CAS# 606-20-2: Draize test, rabbit, skin: 500 mg/24H Mild;
Inhalation, rat: LC50 = 240 mg/m3/6H; Oral, mouse: LD50 = 621 mg/kg;
Oral, rat: LD50 = 177 mg/kg.
CAS# 25321-14-6: Oral, mouse: LD50 = 750 mg/kg.
Carcinogenicity:
2,6-Dinitrotoluene -
California: carcinogen, initial date 7/1/95
IARC: Group 2B carcinogen
Dinitrotoluene (mixed isomers) -
ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to
California: carcinogen, initial date 5/1/96
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: DINITROTOLUENES, SOLID
Hazard Class: 6.1
UN Number: 2038
Packing Group: II
IMO
Shipping Name: DINITROTOLUENES, SOLID
Hazard Class: 6.1
UN Number: 2038
Packing Group: II
RID/ADR
Shipping Name: DINITROTOLUENES
Hazard Class: 6.1
UN Number: 2038
Packing group: II
USA RQ: CAS# 606-20-2: 100 lb final RQ; 45.4 kg final RQ
USA RQ: CAS# 25321-14-6: 10 lb final RQ; 4.54 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 45 May cause cancer.
R 23/24/25 Toxic by inhalation, in contact with skin
and if swallowed.
R 48/22 Harmful : danger of serious damage to health
by prolonged exposure if swallowed.
R 52/53 Harmful to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 606-20-2: 3
CAS# 25321-14-6: No information available.
Canada
CAS# 606-20-2 is listed on Canada's DSL List.
CAS# 25321-14-6 is listed on Canada's DSL List.
CAS# 606-20-2 is not listed on Canada's Ingredient Disclosure List.
CAS# 25321-14-6 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 606-20-2 is listed on the TSCA inventory.
CAS# 25321-14-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 4/13/1998 Revision #3 Date: 7/22/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Trolox, 97%
| 53188-07-1 |
|
Poly(2,2-Dimethyl-1,3-Propylene Succinate) Approximate M.W. 16.000
| 28776-65-0 |
|
1-Benzyl-2-methylimidazole, 95%(gc)
| 13750-62-4 |
|
2-Phenyl-2-imidazoline, 98+%
| 936-49-2 |
|
Pyridazine, 98+%
| 289-80-5 |
|
Butyraldehyde, P.A. Contains Less Than 1% Butyric Acid
| 123-72-8 |
|
2,3-Dimethoxyphenol, 99%
| 5150-42-5 |
|
4-Octylbenzaldehyde, 99% (GC)
| 49763-66-8 |
|
4-Aminophenethyl alcohol, 97% (gc)
| 104-10-9 |
|
2,6-Dinitrotoluene, 99%
| 606-20-2 |
|
Methanethiol, 99.5+%
| 74-93-1 |
|
Benzanilide 98%
| 93-98-1 |
|
2-Amino-6,8-Dihydroxypurine, Tech., ca.85% (HPLC)
| 5614-64-2 |
|
2-Dimethylaminoethyl Methacrylate, 99% (GC), Stabilized
| 150-76-5 |
|
Butyric Acid, Sodium Salt, 99%
| 156-54-7 |
|
N,n',n",n"'-tetraacetylglycoluril, 98+%
| 10543-60-9 |
|
2-Ethylhexyl Acetate, 99% (GC)
| 103-09-3 |
|
Alpha, Alpha, Alpha-Trifluoro-O-Toluic Acid, 98%
| 433-97-6 |
|
Deuterium Oxide, 99.8 Atom % D
| 7789-20-0 |
|
Phenothiazine-10-carbonyl chloride 98%
| 18956-87-1 |
|
4-Chloro-2-Nitrotoluene, 99%
| 89-59-8 |
|
1,12-Dodecanedicarboxylic Acid, 98%
| 821-38-5 |
|
Lead(II) carbonate, basic, -325 mesh
| 1319-46-6 |
|
4'-Chloro-2'-Fluoroacetanilide , 99+%(TLC)
| 59280-70-5 |
|
2-Benzoylbenzoic acid, 98+%
| 85-52-9 |
|
d-(+)-Galactosamine Hydrochloride, 99%
| 1772-03-8 |
|
2-Benzylpyridine, 98%
| 101-82-6 |
|
Trypan Blue
| 72-57-1 |
|
Ethyl caprylate, 99+%
| 106-32-1 |
|
4-(Hydroxymercury)benzoic acid sodium salt
| 138-85-2 |
|
(2S,3S),(2S,3R)-2-Amino-3-Hydroxy-4-Methyl Pentanoic Acid, 99+% e.e.
| 0-01-1 |
|
Ethylenediamine-N,N'-diacetic acid, 98+%
| 5657-17-0 |
|
2-Acetoxy-3,3-dichlorotetrahydrofuran 98+%
| |
|
2-Nitroaniline, 98%
| 88-74-4 |
|
DL-Homatropine Hydrobromide, 98.5-100.5% (on Dry Subst.)
| 51-56-9 |
|
4-Methyl-3-nitroanisole, 99%
| 17484-36-5 |
|
Chromotrope 2b
| 548-80-1 |
|
3-Hydroxytyramine hydrobromide, 99%
| 51-61-6 |
|
1,4-Bis(2-Hydroxyethoxy)-2-Butyne
| 1606-85-5 |
|
Oxonic acid, potassium salt, 97.5%
| 2207-75-2 |
|
(-)-Chiracamphox
| 165038-32-4 |
|
Iminodiacetonitrile, 98%
| 628-87-5 |
|
Heptanoyl chloride, 99%(titr.)
| 2528-61-2 |
|
Azocarmine G (Cert)
| 25641-18-3 |
|
New Coccine
| 2611-82-7 |
|
(2-Fluorophenyl)(4-methoxy-3-nitrophenyl) methanone, 95%
| |
|
1-Chloropropane, 99%
| 540-54-5 |
|
2-Methylglutaric acid, 99%
| 18069-17-5 |
|
3,4,5-Trimethoxyaniline, 97%
| 24313-88-0 |
|
5-Chloro-2-(trichloromethyl)benzimidazole , 95%
| 3584-66-5 |
|
|